Related Articles
TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis
TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway
Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53
LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC
Role of downregulated ADARB1 in lung squamous cell carcinoma